Announcements Trials

Browse Landscape

Phase

Status

Completed 6 Recruiting 5 Withdrawn 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Melanoma 4 Carcinoma, Non-Small-Cell Lung 3 Lung Neoplasms 2 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Solid Tumor 1 Skin Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Inflammatory Breast Neoplasms 1 Gallbladder Neoplasms 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Craniopharyngioma 1 Cholangiocarcinoma 1 Carcinosarcoma 1 Brain Neoplasms 1

Interventions

pembrolizumab 25 Cyclophosphamide 20 Nivolumab 13 Doxorubicin 13 Carboplatin 10 Surveys and Questionnaires 9 Paclitaxel 9 Exercise 9 atezolizumab 8 Vincristine 8 Rituximab 8 Radiotherapy 8 Prednisone 8 Dexamethasone 8 Bevacizumab 8 venetoclax 7 fludarabine 7 Pemetrexed 7 Fluorouracil 7 Docetaxel 7 Blood Specimen Collection 7 lenvatinib 6 dostarlimab 6 cemiplimab 6 budigalimab 6 Oxaliplatin 6 Cisplatin 6 durvalumab 5 Leucovorin 5 Lenalidomide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Neoplasms × cobimetinib × Clear all

NCT03768063 2026-04-28

IMbrella B

Hoffmann-La Roche

Phase 3 Active not recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡